>>The truth is that C19 mainly affects the old and the immune-compromised. I think something like 80%+ of hospitalizations and deaths are with people who are overweight and/or with diabetes or 2+ co-morbidity; situations often (not always) caused by life-style choices one was free to make. Now we will punish our children for decades and decades with the economic and psychological costs of protecting the lives of the very old and the very many who squandered their health. As usual the older generation will make the youth pay for their choices.
>>
>>U.S. COVID-19 deaths 2020-21 by age (year)
>>– 30% of all deaths occurred over the age of 85
>>– 80% of all deaths occurred over the age of 65
>>– Only 15% of the U.S. population is over the age of 65
>>
>>Now just add in the co-morbidity data ...
>>
>>Source: CDC – https://data.cdc.gov/NCHS/AH-Provisional-COVID-19-Death-Counts-by-Age-in-Yea/3apk-4u4f - NB. source is not FoxNews or someone's drunk uncle on Fecebook :)
>
>Some statistics inflate perceived risc, other POV might lessen the panic:
>see case fatalty rate in Hessen (now, even damped by vaccination! in high age group)

> 2021-08-03 	    male           female 	    unknown        CFR
>00-04 Jahre           0            0                  0	      0.00%
>05-14 Jahre           0            0                  0	      0.00%
>15-34 Jahre          23            4                   0	      0.03%
>35-59 Jahre          223          95                   1	      0.28%    
>60-79 Jahre         1500          791                   2	      5.68%
>80+ Jahre           2230         2712                   3         23.02%

>
>with nice pics, well done visualization
>https://rsalzer.github.io/COVID_19_AGE/
>
>or when described as %% against age group in total population
>https://www.aerzteblatt.de/callback/image.asp?id=107168
>
>now to lessen the panic: humans do not like to calculate the risc of dying - but risc of dying is NOT equal at all ages, even if Covid "enhancement" gets more marked with age. See:
>https://www.aerzteblatt.de/callback/image.asp?id=107167
>
>One of the very first targets today has fallen out of favor: "flatten the curve" as to not overburden existing health system. Case mortality fluctuates all over the world, but I found
>https://www.mpg.de/16647475/covid19-unterschiedliche-todesfallraten
>well reasoned approach to explain differences in case fatality between South Korea (2.2%), Germany (4.6%) and outliers Italy (14%) and Spain (12%) with periods of overtaxed hospitals (data from mid-2020)
>
>So concentrate vaccination effort / motivation on 60+ or 50+ first, plus all medical personal as they encounter virus at higher frequency AND concentration, plus all personal working in elderly homes, do not waste effort with "system relevant" groups - fire fighters, policemen can weather it, politicians I won't mention here to stay polite ;-)

I dont read German but it all seems to confirm the same thing; it affects mainly the old and immuno-compromised with obesity being a very significant factor contributing to poor outcomes. Why are we giving this prophylactic therapy to pregnant women and children?

And this excellent news just in: Pfizer Projects $33 Billion in COVID Vaccine Revenues, Driven by Boosters and Vaccines for Kids. Pfizer hiked its projections for COVID vaccine revenues, telling investors this week it expects booster shots, a vaccine targeting the Delta variant and anticipated authorization of its vaccines for children as young as 6 months will drive revenues higher. Strong sales of its COVID vaccine helped Pfizer nearly double second-quarter revenue and boost profits by 59% — beating Wall Street projections and leading the drug giant to sharply hike its 2021 sales and profit forecasts. During a July 28 second quarter earnings call, Pfizer told investors the company has increased its revenue projection, now expected to be in the range of $78 to $80 billion. The company projected revenue from its COVID vaccine alone will hit $33.5 billion — a 29% jump from the previously estimated $26 billion. Pfizer registered $7.8 billion in COVID vaccine sales in the second quarter, bringing total worldwide sales so far this year to $11.3 billion.

And more good news for the EU: Per the latest supply deals signed by the EU, the prices of COVID-19 vaccines developed by Pfizer/BioNTech and Moderna have risen by more than 25% and 10%, respectively, The Financial Times reported.